Teng, Y., Jin, H., Liu, Z., Li, D., Ye, X., Yang, L., & Zhou, J. (2020). The Lyn-SIRT1 signaling pathway is involved in imatinib resistance in chronic myeloid leukaemia. Am J Transl Res.
Chicago-tyylinen lähdeviittausTeng, Yue-Qiu, Hua Jin, Zhi-Yu Liu, Dan-Dan Li, Xiang-Mei Ye, Lu-Yuan Yang, ja Jin Zhou. "The Lyn-SIRT1 Signaling Pathway Is Involved in Imatinib Resistance in Chronic Myeloid Leukaemia." Am J Transl Res 2020.
MLA-viiteTeng, Yue-Qiu, et al. "The Lyn-SIRT1 Signaling Pathway Is Involved in Imatinib Resistance in Chronic Myeloid Leukaemia." Am J Transl Res 2020.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.